Drug Trial Radar · NCT07076342
The Role of mGluR5 in CBT-I
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
42
Planned (sponsor's estimate)
Start
Aug 1, 2025
Primary completion
Mar 31, 2030
Study completion Mar 31, 2030
Sponsor
- Lead sponsor
- Stony Brook UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institutes of Health (NIH); National Institute of Mental Health (NIMH)
- First posted
- Jul 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is mechanistic clinical trial that evaluates the role of one of the glutamate receptors (mGluR5) in cognitive behavioral therapy for insomnia (CBT-I) as a common pathway in improving sleep and depression.
Conditions
- Major Depressive Disorder (MDD)
Interventions
Cognitive Behavioral Therapy for InsomniaBehavioral
Cognitive Behavioral Therapy for Insomnia (CBT-I) will be delivered through an online program, Sleep Healthy Using The Internet Sleep Healthy Using The Internet (SHUTi)
PET Scan with [11C]ABP688Drug
Prior to and after completing the CBT-I protocol, participants will undergo a PET scan using tracer \[11C\]ABP688) to quantify hippocampal mGluR5 density.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Sleep Latency from Baseline to 8 WeeksTime frame: Baseline and 8 Weeks
- Change from Baseline of mGluR5 density in the hippocampus after 8 weeks of CBT-I TreatmentTime frame: Baseline and 8 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Stony Brook University: Dept of Psychiatry
Stony Brook, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.